Manulife (Manufacturers Life Insurance)
CLYM

Manulife (Manufacturers Life Insurance)’s Climb Bio CLYM Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.07M Buy
156,317
+15,700
+11% +$90.6K ﹤0.01% 1800
2025
Q4 		$567K Buy
140,617
+101,717
+261% +$244K ﹤0.01% 2123
2025
Q3 		$78.2K Hold
38,900
– – ﹤0.01% 2821
2025
Q2 		$48.2K Sell
38,900
-1,225
-3% -$1.52K ﹤0.01% 2892
2025
Q1 		$49K Buy
40,125
+1,225
+3% +$1.99K ﹤0.01% 2837
2024
Q4 		$70K Sell
38,900
-10,624
-21% -$38.4K ﹤0.01% 2887
2024
Q3 		$252K Buy
+49,524
New +$350K ﹤0.01% 2560

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CLYM Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Climb Bio (CLYM) stake by 11% in Q1 2026, buying an estimated $90.6K and bringing the position to 156,317 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1800.

Manulife (Manufacturers Life Insurance) first reported a position in CLYM in Q3 2024 and has held it in 7 quarters since. 80 funds tracked by Wall St. Rank hold CLYM as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 156,317 shares of Climb Bio worth $1.07M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 15,700 Climb Bio shares in Q1 2026, an estimated $90.6K.
  • Climb Bio made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1800 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Climb Bio in Q3 2024 and has held it in 7 quarters since.
  • 80 funds tracked by Wall St. Rank held Climb Bio as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.